Selank Side Effects

Reported Selank side effects

Overall Safety Profile Selank has one of the best safety profiles in the anxiolytic space. Over 15+ years of Russian clinical use and research, the compound has been associated with essentially no serious adverse events at therapeutic doses. This compares favorably to: Benzodiazepines: Sedation, cognitive impairment, dependence, withdrawal, paradoxical effects, respiratory depression with opioids SSRIs: Sexual dysfunction, weight changes, emotional blunting, discontinuation syndrome, initial activation/anxiety Buspirone: Dizziness, headache, less reliable efficacy Alcohol: Addiction, liver damage, cognitive decline, social/occupational dysfunction Selank's favorable profile is one of the primary reasons for its popularity in the biohacking community. That said, all medications have side effects, and Selank is no exception. Common Side Effects (5-15%) Nasal irritation (10-15% at higher doses): Mild burning, dryness, or discomfort in nasal passages from the spray vehicle. Usually resolves with continued use or is mild enough not to require intervention. Mild headache (5-10%): Especially with first few doses; typically mild and self-limiting. Altered taste (5-10%): Some users report a brief bitter or salty taste after intranasal dosing as medication drips down the posterior nasopharynx. Mild fatigue or relaxation (5-8%): Most users experience this as a pleasant "calm alertness," but a minority perceive it as mild fatigue, especially at higher doses. Uncommon Side Effects (1-5%) Nausea: Mild; typically with higher doses or on empty stomach Dizziness: Usually mild and self-limiting Mood changes: Rarely, paradoxical anxiety or mood changes Dry mouth: Mild Sleep disturbances: Usually improved sleep rather than disturbed, but occasional users report altered sleep architecture Vivid dreams: Uncommon but reported Rare Side Effects (<1%) Allergic reactions: Theoretical risk; rare with peptides Injection site reactions (for SC users): Mild redness if injected rather than intranasal Paradoxical anxiety: Rare; if occurs, usually early in course What Has NOT Been Reported The following adverse events, common with other anxiolytics, have NOT been associated with Selank: Dependence or addiction potential Withdrawal syndrome Tolerance requiring dose escalation Cognitive impairment Memory problems Psychomotor slowing Respiratory depression Sexual dysfunction Weight changes Emotional blunting Complex sleep behaviors Seizure liability QT prolongation or cardiac effects Serotonin syndrome (when combined with SSRIs — though caution is prudent) This absence of adverse events reflects both the limited exposure in rigorous trials AND the genuinely favorable pharmacological profile. Dose-Dependent Patterns Side effects increase with dose: 150 mcg (standard single dose): Minimal to no side effects in most users 300 mcg: Occasional mild nasal irritation or headache 600 mcg: More prominent nasal effects; slightly more users report mild fatigue 900 mcg: Higher rate of minor side effects; still well tolerated in most >900 mcg/day: Rarely used; limited data on tolerability Delivery Route Considerations Intranasal (standard): Primary route with most safety data Most side effects (if any) are local nasal effects Systemic effects generally mild Subcutaneous injection (off-label in biohacking): Possible injection site reactions May feel slightly more "systemic" due to greater plasma exposure Less well-characterized safety profile than intranasal Drug Interactions Formal drug interaction studies for Selank are limited. Based on pharmacology: No significant interactions with CYP enzymes (peptide; not metabolized by liver) Theoretical additive effect with other anxiolytics (benzodiazepines, buspirone): usually safely combined in Russian practice, but not necessary in most cases SSRIs/SNRIs: No evidence of problematic interaction; Selank can be used as adjunct Sedating medications: Generally minimal additive effect given Selank's non-sedating profile Alcohol: No known interaction; alcohol itself disrupts mood/anxiety and should be moderated Stimulants (caffeine, modafinil): No known interaction; some users pair Selank with stimulants to counterbalance stimulant-induced anxiety Other research peptides (Semax, DSIP): Commonly stacked; no reported concerning interactions Long-Term Safety Data Long-term data from Russian clinical experience over 15+ years suggests: Sustained efficacy with intermittent use No cumulative toxicity No cognitive decline with long-term use No endocrine disruption Suitable for use in elderly populations at standard doses Special Populations Elderly: Standard doses appropriate; monitor for mild fatigue; no dose reduction typically required. Pregnancy and lactation: No data. Avoid. Pediatric: Limited data in pediatric populations; some use in Russia for anxiety in children, but Western practice would be to avoid in minors. Hepatic or renal impairment: Minimal concern given peptide pharmacokinetics not significantly affected by liver/kidney function. Psychiatric history: Generally safe adjunct to established psychiatric treatment; not a substitute for indicated care in serious conditions. Discontinuation No taper required No withdrawal syndrome Anxiety-relieving effects cease over days as BDNF normalizes Can be restarted at any time at previous effective dose Periodic breaks are sensible both for drug holidays and to maintain sensitivity Red Flags Requiring Discontinuation or Medical Evaluation Severe nasal pain or bleeding (rare; may indicate irritation) Any allergic reaction (rash, swelling, breathing difficulty) Paradoxical anxiety or mood worsening Unexpected significant mood changes in either direction Symptoms suggesting serotonin syndrome if combined with SSRIs (very rare) Occupational Safety Selank does NOT produce sedation, cognitive impairment, or psychomotor slowing at therapeutic doses in the vast majority of users. Driving, operating machinery, and cognitive-demanding work are not typically restricted. Users with unusual sensitivity should verify their individual response before safety-critical activities. Athletic Testing Considerations Selank is not currently on the World Anti-Doping Agency (WADA) prohibited list as of current reference, but regulations change. Competitive athletes should verify current status with their sport's governing body. Research peptides are under increasing regulatory scrutiny.

When to continue, reduce, or stop Selank

Selank contraindications

Absolute Contraindications Selank should NOT be used in the following circumstances: Known allergy or hypersensitivity to Selank or components Pregnancy: Insufficient safety data; peptide effects on developing nervous system not characterized Lactation: Insufficient safety data Active psychosis or severe psychiatric emergencies: Requires specialist management with established medications Severe untreated medical conditions potentially manifesting as anxiety: Thyrotoxicosis, pheochromocytoma, arrhythmia — treat the underlying condition Relative Contraindications / Caution Warranted Pediatric use: Limited data; some Russian clinical use in children but Western practice would be to avoid Moderate to severe liver disease: Peptide clearance generally preserved but data in severe hepatic impairment is limited Moderate to severe kidney disease: Same consideration Active substance use disorder: Selank itself not addictive, but complete treatment approach needed Severe anxiety requiring urgent care: Selank is adjunctive; severe panic or suicidal anxiety need professional evaluation Nasal pathology: Chronic rhinitis, deviated septum, nasal polyps may impair absorption; consider injection route or treat nasal condition Psychiatric Considerations Active suicidal ideation: Professional psychiatric care is primary; Selank is not sufficient alone Severe depression: Selank has modest mood effect; not a substitute for antidepressants in major depression PTSD: Selank may be useful adjunct but complete trauma-focused care (therapy, sometimes medication) is primary Bipolar disorder: Manic or hypomanic episodes require specific management; Selank has no established role in mood stabilization Panic disorder: May help but often insufficient; complete CBT ± SSRI is first-line OCD: Modest effect possible but high-dose SSRI is first-line Drug Interactions Formal interaction studies are limited. Based on pharmacology: SSRIs/SNRIs: No known dangerous interaction; combination sometimes useful; theoretical serotonin syndrome concern with very high doses of either MAOIs: Theoretical concern due to serotonergic component; prudent to avoid Tricyclic antidepressants: No significant interaction expected Benzodiazepines: Combined often useful, no dangerous interaction; additive anxiolysis (desired) Buspirone: Compatible combination Opioids: Theoretical interaction via opioid system modulation; clinically non-problematic in limited reports Alcohol: No dangerous interaction; but alcohol disrupts anxiety management Stimulants: No dangerous interaction; may counter stimulant anxiety Antipsychotics: No specific interactions noted Lithium: No known interaction Anticonvulsants: No known interaction Other research peptides (Semax, DSIP, etc.): Commonly stacked without reported issues Medical Conditions Requiring Caution Cardiovascular disease: No specific CV effects noted, but any new medication in unstable CV disease requires consideration Endocrine disorders: Thyroid dysfunction should be treated — anxiety may have endocrine cause Chronic respiratory disease: Peptide itself is respiration-neutral; nasal delivery may irritate in severe rhinitis/sinusitis Migraine disorders: No specific interaction; nasal spray may worsen migraine in some sensitive users Seizure disorders: No known effect on seizure threshold; baseline caution with any neuroactive compound Immunocompromised states: Selank's immunomodulatory effects are mild but discuss with treating physician Contraindicated Combinations While Selank is generally safe in combination, these combinations warrant specific caution: MAOIs + Selank: Theoretical serotonin syndrome risk; avoid Multiple serotonergic agents at high doses: SSRI + SNRI + Selank + 5-HTP + St. John's wort — serotonin toxicity risk Multiple sedatives: Selank + benzodiazepine + alcohol + opioid — additive CNS effects Complex polypharmacy without physician oversight: Unpredictable interactions Physical Examination and Workup Before Starting For anxiety that has not been medically evaluated: TSH and free T4: Hyperthyroidism presents as anxiety Caffeine intake assessment: Common overlooked cause Substance use history: Cannabis, stimulants, alcohol — treat underlying issue Sleep evaluation: Poor sleep causes anxiety Cardiac evaluation if palpitations/chest symptoms: EKG, consider Holter B12, folate, vitamin D: Deficiencies can manifest as mood/anxiety symptoms Blood glucose, HbA1c: Dysglycemia affects mood Testosterone if male: Low T associated with anxiety in some men Menopausal status if female: Perimenopausal anxiety common Medication review: Current medications that could contribute to anxiety Safety Monitoring Selank itself doesn't require specific lab monitoring. General wellness monitoring is reasonable as part of broader health maintenance. Symptoms warranting discontinuation or medical evaluation: Severe or unusual headache Any allergic-type reaction Unexpected mood changes (severe depression, mania, psychosis) Worsening rather than improving anxiety Physical symptoms suggesting systemic reaction Pregnancy and Fertility No data in pregnancy or lactation. Avoid. Effects on fertility: Not documented in either direction. For couples trying to conceive: prudent to avoid the female partner's use; male use less concerning but data absent. Pediatric Use Some Russian clinical use in children with anxiety exists, but: Western practice would typically avoid in minors Non-pharmacological interventions (therapy, environmental modification, behavioral support) should be primary If medication indicated, established pediatric psychiatric care with approved agents is preferred Elderly Considerations Standard doses typically appropriate: Start at 150 mcg to assess tolerability Monitor for mild fatigue (uncommon but possible) No specific dose reduction required Favorable cognitive profile compared to benzodiazepines (which are discouraged in elderly) Useful option in elderly where BZDs are problematic Driving and Machinery Selank does NOT impair driving, coordination, or reaction time at therapeutic doses in the vast majority of users. Assess individual response before safety-critical activities. Most users experience no impairment at any dose. Occupational Considerations Not on current WADA prohibited list (verify before competition) Not routinely tested in workplace drug screening Not scheduled/controlled in most jurisdictions (exception: Russia treats as prescription) Safety-critical professions (pilots, surgeons, operators): verify individual tolerance Long-Term Use Philosophy While Selank appears safe for long-term use based on Russian clinical experience (15+ years of approval), the spirit of good pharmacology is to: Use the minimum dose that achieves the goal Periodic breaks rather than continuous use Combine with non-pharmacological approaches (therapy, lifestyle) Regularly reassess ongoing need Avoid drift toward polypharmacy without clear rationale Indefinite nightly use of any anxiolytic, even a safe one, reflects either (1) untreated underlying condition, (2) lifestyle factors not addressed, or (3) psychological dependence that may benefit from reassessment. The goal is flexibility and function, not permanent pharmacology.

Why vendor quality drives Selank side-effect frequency

Research-compound communities consistently report that adverse-event frequency tracks with source quality. Three reasons: (1) impurity profiles vary by lab (residual synthesis byproducts can trigger reactions); (2) mislabeled mass means actual dose can be 50-150% of stated dose; (3) reconstitution-grade water and capping methodology affect long-term storage stability. COA-verified vendors with published HPLC data minimize all three failure modes. Check a vendor's COA record and Trust Score before you buy.

Selank side effects FAQ

Research-use disclaimer. All safety information on this page summarizes published research literature and community-reported reactions. It is not medical advice and not authorization for human consumption. Always consult a licensed practitioner before any compound enters a clinical context. Compounds linked from this page are sold for research-use only.
Affiliate disclosure. See our affiliate disclosure .